tiprankstipranks
NeuroBo Pharmaceuticals (NRBO)
NASDAQ:NRBO
US Market
Holding NRBO?
Track your performance easily

NeuroBo Pharmaceuticals (NRBO) Financial Statements

329 Followers

NeuroBo Pharmaceuticals Financial Overview

NeuroBo Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-4.77; its P/E ratio is -0.50; NeuroBo Pharmaceuticals is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is $-0.49. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -5.96M$ -10.22M$ -6.95M$ -3.89M$ -734.00K
EBITDA$ -5.95M$ -10.21M$ -6.95M$ -3.89M$ -734.00K
Net Income Common Stockholders$ -5.65M$ -10.05M$ -6.71M$ -3.82M$ -734.00K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 21.70M$ 27.93M$ 16.00M$ 25.80M$ 28.70M
Total Assets$ 22.15M$ 28.75M$ 17.02M$ 26.43M$ 29.18M
Total Debt$ 154.00K$ 170.00K$ 187.00K$ 65.00K$ 0.00
Net Debt$ -21.55M$ -27.76M$ -15.81M$ -25.73M$ -28.70M
Total Liabilities$ 9.19M$ 9.81M$ 6.94M$ 4.88M$ 3.98M
Stockholders Equity$ 12.95M$ 18.94M$ 10.08M$ 21.55M$ 25.20M
Cash Flow-
Free Cash Flow$ -5.61M$ -7.30M$ -6.41M$ -2.85M$ -2.04M
Operating Cash Flow$ -5.61M$ -7.29M$ -6.40M$ -2.81M$ -2.04M
Investing Cash Flow-$ -3.00K$ -5.00K$ -37.00K-
Financing Cash Flow$ -676.00K$ 19.20M--$ -80.00K
Currency in USD

NeuroBo Pharmaceuticals Earnings and Revenue History

NeuroBo Pharmaceuticals Debt to Assets

NeuroBo Pharmaceuticals Cash Flow

NeuroBo Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis